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Metabolic syndrome is a complex of metabolic disorders and the 
consequences of these processes. Many international medical organizations develop 
criteria by which to diagnose metabolic syndrome in patients. In 2009, the 
document «Harmonization of the definition of the metabolic syndrome» was 
published, which was signed by leading medical organizations and communities. 
In 1981 the term «metabolic syndrome» has been designated as a 
combination of different instances of metabolic disorders. In 1988, Professor 
G.Reaven suggested that this pathological condition called «syndrome X».  Later 
D. Kaplan introduced the term «deadly quartet» - diabetes, obesity, hypertension, 
coronary heart diseases. 
In industrialized countries, the prevalence of metabolic syndrome among 
persons over 30 years of 10-20% in the USA - 34%. It was believed that the 
metabolic syndrome is a disease of middle-aged people and mainly women. 
However, conducted under the auspices of the American Diabetes Association 
survey shows that this syndrome indicates a steady increase among the younger 
generation. 
Among these states, obesity has a major effect on the joints with a load or 
without. Mechanical overload and activity system inflammatory mediators isolated 
from adipose tissue (adipokines, reactive oxygen species, free fatty acid), give an 
impetus to increase the incidence and prevalence of osteoarthritis in obesity. 
Cartilage degradation results from broken joint homeostasis that favors catabolic 
processes activated by pro-inflammatory mediators, which are produced as well by 
chondrocytes, synoviocytes and osteoblasts.  
During the past years, obesity and metabolic disorders have been found 
related to systemic chronic inflammation characterized by abnormal cytokine 
production, increased levels of acute-phase reactants and activation of a network of 
inflammatory signaling pathways. Fat mass is the main of this inflammation, but 
diabetes, dyslipidemia and hypertension have specific involvement in metabolic 
inflammation, which could be implicated in osteoarthritis pathogenesis. Now 
harmful biological effects of fatty tissue and abnormal metabolism topically in a 
joint in conjunction with inflammatory factors are considered. And the common 
hypothesis is that metabolic disturbances precede and induce systemic chronic 
inflammation, which causes joint deterioration. Another theory has said the concept 
of «inflammaging» (for inflammation and aging), with inflammation as the direct 
consequence of aging. Aging is associated with cellular senescence, 
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immunosenescence, debris accumulation and harmful products leading to 
exacerbated and sustained proinflammatory processes. 
Osteoarthritis is a chronic joint disease leading to cartilage degradation, that 
includes synovial inflammation, subchondral bone remodeling and the formation of 
osteophytes. Cartilage degradation results from ruptured joint homeostasis that 
favors catabolic processes activated by pro-inflammatory mediators (lipid 
mediators, cytokines and reactive oxygen species), which are produced by 
osteoblasts, chondrocytes, synoviocytes. These products are responsible for altering 
anabolism and release of proteolytic enzymes degrading extracellular matrix. 
Osteoarthritis is classified according to risk factors, such as aging, genetics, trauma, 
obesity and metabolic disorders. Despite an identical outcome, pathological paths 
differ depending on the cause. 
Osteoarthritis is the most common form of arthritis. This pathology is the 
leader in disability among adults with a primary lesion of the knee joint. 
Osteoarthritis is a degenerative joint disease that develops in the aging process and 
is characterized by focal destruction of cartilage. Despite the widespread, its 
etiology remains controversial. There is only one type of cell is a cartilage, the 
chondrocyte, which is responsible for its repair and synthesis of extracellular 
matrix components constant. Dysfunction of these cells leads to an imbalance 
between the recovery and the damage in the cartilage, leading to its destruction. 
Recently introduced the concept of metabolic syndrome - associated osteoarthritis, 
pointing to the inseparable link in the pathogenesis of osteoarthritis, and metabolic 
syndrome. Metabolic syndrome - associated osteoarthritis is characterized by a 
complex of factors (insulin resistance, hypertension, dyslipidemia, visceral 
obesity), although there is still no clear definition of it. During the 20th century, the 
prevalence of metabolic syndrome - associated osteoarthritis increased dramatically 
with changes in lifestyle of the population, gaining momentum scale health 
problem in industrialized countries. Metabolic syndrome - associated osteoarthritis 
concerns 10-30% of the world's population, but is prevalent in 58% of patients with 
osteoarthritis. Patients with osteoarthritis as metabolic syndrome - associated 
osteoarthritis have more severe symptoms and conditions that it is earlier than the 
other healthy individuals. Indeed, osteoarthritis, as a rule, the disease on the 
population over the age of 65 years, but with metabolic syndrome - associated 
osteoarthritis target population is about 50 years. 
Obesity is characterized by not only an excessive load on the joints, but also 
changes in the lipid profile, - dyslipidemia. Characteristic of obesity is the 
formation of foci of chronic inflammation in the fat tissue. If normal adipose tissue 
contains anti-inflammatory macrophages, directly the adipose tissue of obese 
abundance of inflammatory macrophages. Cells of adipose tissue-adipocytes 
secrete cytokines. It is yet another piece to the development of inflammation. The 
study of foreign scientists reflects the fact, that the metabolic changes in the lipid 
profile are important in osteoarthritis development processes. High cholesterol 
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levels in blood serum determines the development of osteoarthritis. Thus we can 
say that cholesterol - the formation of osteoarthritis predictor as chondrocytes 
accumulate lipids. The amount of intracellular oxidation of lipids is positively 
correlated with osteoarthritis. 
Next to age, obesity is one of the main predictors of the development of 
osteoarthritis. The link between obesity and osteoarthritis is a multi-unit. Definitely 
it was considered that excess weight leads to wear and tear seam. In fact, excessive 
load leads to cartilage degradation and subchondral bone shows that weight plays 
an important role in the initiation and development of osteoarthritis. However, the 
weight is correlated with obesity, osteoarthritis no weight-bearing joints. 
 
 
